PainReform Statistics
Total Valuation
PainReform has a market cap or net worth of $2.32 million. The enterprise value is -$408,490.
Important Dates
The next estimated earnings date is Tuesday, November 26, 2024, before market open.
| Earnings Date | Nov 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PainReform has 556,613 shares outstanding. The number of shares has increased by 219.33% in one year.
| Current Share Class | 2.23M |
| Shares Outstanding | 556,613 |
| Shares Change (YoY) | +219.33% |
| Shares Change (QoQ) | +71.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 31.67% |
| Float | 2.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.61
| Current Ratio | 0.61 |
| Quick Ratio | 0.57 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -716.67% and return on invested capital (ROIC) is -446.45%.
| Return on Equity (ROE) | -716.67% |
| Return on Assets (ROA) | -195.07% |
| Return on Capital (ROIC) | -446.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.52M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PainReform has paid $8,000 in taxes.
| Income Tax | 8,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.86% in the last 52 weeks. The beta is 0.56, so PainReform's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -91.86% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 4.50 |
| Relative Strength Index (RSI) | 61.57 |
| Average Volume (20 Days) | 10,066,279 |
Short Selling Information
The latest short interest is 121,076, so 21.75% of the outstanding shares have been sold short.
| Short Interest | 121,076 |
| Short Previous Month | 61,074 |
| Short % of Shares Out | 21.75% |
| Short % of Float | 5.44% |
| Short Ratio (days to cover) | 0.38 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.83M |
| Pretax Income | -12.53M |
| Net Income | -17.67M |
| EBITDA | -17.81M |
| EBIT | -17.83M |
| Earnings Per Share (EPS) | -$30.57 |
Full Income StatementBalance Sheet
The company has $2.78 million in cash and $59,000 in debt, giving a net cash position of $2.72 million or $4.89 per share.
| Cash & Cash Equivalents | 2.78M |
| Total Debt | 59,000 |
| Net Cash | 2.72M |
| Net Cash Per Share | $4.89 |
| Equity (Book Value) | -2.04M |
| Book Value Per Share | -3.53 |
| Working Capital | -1.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.37 million and capital expenditures -$21,000, giving a free cash flow of -$11.39 million.
| Operating Cash Flow | -11.37M |
| Capital Expenditures | -21,000 |
| Free Cash Flow | -11.39M |
| FCF Per Share | -$20.46 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |